Farah J, Mares V, Romero-Expósito M, Trinkl S, Domingo C, Dufek V, Klodowska M, Kubancak J, Knežević Ž, Liszka M, Majer M, Miljanić S, Ploc O, Schinner K, Stolarczyk L, Trompier F, Wielunski M, Olko P, Harrison R M
Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Radioprotection de l'Homme, BP17, Fontenay-aux-Roses 92260, France.
Helmholtz Zentrum München, Institute of Radiation Protection, Ingolstädter Landstraße 1, Neuherberg 85764, Germany.
Med Phys. 2015 May;42(5):2572-84. doi: 10.1118/1.4916667.
To characterize stray radiation around the target volume in scanning proton therapy and study the performance of active neutron monitors.
Working Group 9 of the European Radiation Dosimetry Group (EURADOS WG9-Radiation protection in medicine) carried out a large measurement campaign at the Trento Centro di Protonterapia (Trento, Italy) in order to determine the neutron spectra near the patient using two extended-range Bonner sphere spectrometry (BSS) systems. In addition, the work focused on acknowledging the performance of different commercial active dosimetry systems when measuring neutron ambient dose equivalents, H(∗)(10), at several positions inside (8 positions) and outside (3 positions) the treatment room. Detectors included three TEPCs--tissue equivalent proportional counters (Hawk type from Far West Technology, Inc.) and six rem-counters (WENDI-II, LB 6411, RadEye™ NL, a regular and an extended-range NM2B). Meanwhile, the photon component of stray radiation was deduced from the low-lineal energy transfer part of TEPC spectra or measured using a Thermo Scientific™ FH-40G survey meter. Experiments involved a water tank phantom (60 × 30 × 30 cm(3)) representing the patient that was uniformly irradiated using a 3 mm spot diameter proton pencil beam with 10 cm modulation width, 19.95 cm distal beam range, and 10 × 10 cm(2) field size.
Neutron spectrometry around the target volume showed two main components at the thermal and fast energy ranges. The study also revealed the large dependence of the energy distribution of neutrons, and consequently of out-of-field doses, on the primary beam direction (directional emission of intranuclear cascade neutrons) and energy (spectral composition of secondary neutrons). In addition, neutron mapping within the facility was conducted and showed the highest H(∗)(10) value of ∼ 51 μSv Gy(-1); this was measured at 1.15 m along the beam axis. H(∗)(10) values significantly decreased with distance and angular position with respect to beam axis falling below 2 nSv Gy(-1) at the entrance of the maze, at the door outside the room and below detection limit in the gantry control room, and at an adjacent room (<0.1 nSv Gy(-1)). Finally, the agreement on H(∗)(10) values between all detectors showed a direct dependence on neutron spectra at the measurement position. While conventional rem-counters (LB 6411, RadEye™ NL, NM2-458) underestimated the H(∗)(10) by up to a factor of 4, Hawk TEPCs and the WENDI-II range-extended detector were found to have good performance (within 20%) even at the highest neutron fluence and energy range. Meanwhile, secondary photon dose equivalents were found to be up to five times lower than neutrons; remaining nonetheless of concern to the patient.
Extended-range BSS, TEPCs, and the WENDI-II enable accurate measurements of stray neutrons while other rem-counters are not appropriate considering the high-energy range of neutrons involved in proton therapy.
表征扫描质子治疗中靶区周围的杂散辐射,并研究有源中子监测器的性能。
欧洲辐射剂量学小组第9工作组(EURADOS WG9 - 医学中的辐射防护)在意大利特伦托质子治疗中心开展了一项大型测量活动,以使用两个扩展量程的邦纳球谱仪(BSS)系统确定患者附近的中子能谱。此外,该工作重点在于了解不同商用有源剂量学系统在测量治疗室内(8个位置)和室外(3个位置)多个位置的中子周围剂量当量H(∗)(10)时的性能。探测器包括三个组织等效正比计数器(TEPC)——Far West Technology公司的Hawk型以及六个剂量仪(WENDI - II、LB 6411、RadEye™ NL、一个常规型和一个扩展量程的NM2B)。同时,杂散辐射的光子成分可从TEPC能谱的低线性能量转移部分推导得出,或使用赛默飞世尔科技公司的FH - 40G巡测仪进行测量。实验使用了一个代表患者的水箱模体(60×30×30 cm³),该模体使用直径为3 mm的质子笔形束进行均匀照射,调制宽度为10 cm,束流远端射程为19.95 cm,射野尺寸为10×10 cm²。
靶区周围的中子能谱在热中子和快中子能区显示出两个主要成分。该研究还揭示了中子能量分布以及因此产生的野外剂量对初级束方向(核内级联中子的定向发射)和能量(次级中子的能谱组成)的强烈依赖性。此外,在该设施内进行了中子绘图,结果显示最高的H(∗)(10)值约为51 μSv Gy⁻¹;这是在沿束轴1.15 m处测得的。H(∗)(10)值随着与束轴的距离和角度位置显著降低,在迷宫入口处、房间门外以及龙门控制室低于探测限,在相邻房间(<0.1 nSv Gy⁻¹)时降至2 nSv Gy⁻¹以下。最后,所有探测器之间H(∗)(10)值的一致性表明其直接依赖于测量位置处的中子能谱。虽然传统剂量仪(LB 6411、RadEye™ NL、NM2 - 458)对H(∗)(10)的低估高达4倍,但发现Hawk TEPC和WENDI - II扩展量程探测器即使在最高中子注量和能量范围内也具有良好性能(误差在20%以内)。同时,发现次级光子剂量当量比中子低达五倍;尽管如此,对患者来说仍是一个需要关注的问题。
扩展量程的BSS、TEPC和WENDI - II能够准确测量杂散中子,而考虑到质子治疗中涉及的中子高能范围,其他剂量仪并不适用。